ASCO 2018 – Friday 1st and Saturday 2nd June: Bluebird Bio’s CAR … – pharmaphorum
pharmaphorum |
ASCO 2018 – Friday 1st and Saturday 2nd June: Bluebird Bio's CAR …
pharmaphorum The American Society of Clinical Oncology (ASCO) has already singled out CAR-T therapies as the most promising advance in cancer therapy this year – and … Celgene (CELG), bluebird bio (BLUE) Phase I Study of bb2121 … |
